INTECH Investment Management’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.44M | Sell |
4,408
-1,490
| -25% | -$486K | 0.01% | 982 |
|
|
2025
Q1 | $1.59M | Sell |
5,898
-1,675
| -22% | -$452K | 0.02% | 896 |
|
|
2024
Q4 | $1.78M | Buy |
7,573
+428
| +6% | +$101K | 0.02% | 778 |
|
|
2024
Q3 | $1.97M | Hold |
7,145
| – | – | 0.02% | 490 |
|
|
2024
Q2 | $1.74M | Sell |
7,145
-3,740
| -34% | -$909K | 0.02% | 481 |
|
|
2024
Q1 | $1.63M | Buy |
10,885
+3,344
| +44% | +$500K | 0.02% | 394 |
|
|
2023
Q4 | $1.44M | Sell |
7,541
-3,689
| -33% | -$706K | 0.02% | 380 |
|
|
2023
Q3 | $1.99M | Buy |
11,230
+2,864
| +34% | +$507K | 0.03% | 350 |
|
|
2023
Q2 | $1.59M | Sell |
8,366
-28,799
| -77% | -$5.47M | 0.02% | 398 |
|
|
2023
Q1 | $7.44M | Buy |
37,165
+11,093
| +43% | +$2.22M | 0.06% | 323 |
|
|
2022
Q4 | $6.2M | Buy |
26,072
+10,149
| +64% | +$2.41M | 0.05% | 351 |
|
|
2022
Q3 | $3.19M | Buy |
15,923
+8,587
| +117% | +$1.72M | 0.02% | 398 |
|
|
2022
Q2 | $1.07M | Buy |
+7,336
| New | +$1.07M | 0.01% | 518 |
|